Valence 로고
인기
로그인

관심목록에 추가

Aclarion Inc.

NasdaqCM: ACONW · 실시간 가격 · USD
0.03
+0.00 (0.00%)
종가 기준: Aug 20, 2026, 3:17 PM

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

Aclarion Inc.(ACONW) 주가, 분석 및 데이터

0.00%
매수호가n/a
시가총액n/a
매출 (ttm)83.77K
순이익 (ttm)-9.2M
1.22
-6.58
n/a
n/a
P/B (ttm)n/a
P/S (ttm)n/a
실적 발표일n/a
매도호가n/a
거래량25,336
평균 거래량 (20일)
시가0.05
전일 종가0.03
일중 범위0.03 - 0.03
52주 범위0.03 - 0.03
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

ACONW 소개

Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercial...

[더 보기]
산업
섹터
IPO 일자 Jul 17, 2026
직원 수 10
상장 거래소 NasdaqCM
티커 ACONW
웹사이트 https://www.aclarion.com
전체 기업 정보

재무 실적

2025년 Aclarion의 매출은 75.73K로, 전년 45.72K 대비 65.62% 증가했습니다. 순이익은 -7.23M로, 3.44% 증가했습니다.

재무제표
news image

2주 전 · Zacks

Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates

Aclarion (ACON) delivered earnings and revenue surprises of -6.67% and -15.97%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

news image

3개월 전 · Zacks

Aclarion (ACON) Upgraded to Buy: Here's Why

Aclarion (ACON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

news image

3개월 전 · Zacks

Aclarion, Inc. (ACON) Reports Q1 Loss, Misses Revenue Estimates

Aclarion (ACON) delivered earnings and revenue surprises of +13.55% and -29.53%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?